Tigilanol tiglate is an oncolytic small molecule that induces immunogenic cell death and enhances the response of both target and non-injected tumors to immune checkpoint blockade
Article in Journal for ImmunoTherapy of Cancer (April 2024)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Article in Journal for ImmunoTherapy of Cancer (April 2024)
Article in Veterinary Sciences (April 2024)
Article in Veterinary Clinics of North America Small Animal Practice (January 2024)